Closed transaction

Identification of OTC pharma business acquisition opportunity and advice to the buyer

Advised by
Client
Counterparty
Dômes Pharma
Deal stage
Closed transaction
Service
Buy
Sector
Healthcare
Sub-sector
Biotech/Pharma Services
Market
EMEA
Contact
kurmann@juergkurmann.com

Deal details

Identification that the human OTC business of the French veterinary group Dômes Pharma was non-core and originating negotiations with Schaer Pharma who we advsided throughout the whole process. After a share deal collapsed in December 2017 an asset deal was closed in June 2018.

Juerg Kurmann RoleAssociate Partner FirmHoffmann & Partner Juerg joined H&P as an Associate Partner in 2018 and as of 2021 became a member of H&P’s Board of Directors. View profile

Hoffmann & Partner latest deals

Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

House of Flexwork was acquired by Synergie Group.

Where
Switzerland
Year
2026

More by Hoffmann & Partner

More deals in Healthcare

Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Switzerland
Year
2025

More Healthcare

More deals in Europe

Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026
Buy-side advisory

The Vella Group acquired RGM Vehicle Body Repairs.

Where
United Kingdom
Year
2026
Sell-side advisory

Elite Vehicle Supplies received investment from Vehicle Accessories Solutions Ltd T/A Motormax.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

Contact us